GSK PLC (GLAXF:OTCMKTS)
$24 0.49 (2.0842%)
Analysed GSK PLC (GLAXF:OTCMKTS) News Sources
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
03-09-2026
yahoo.com
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says
04-09-2026
proactiveinvestors.com
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense
04-09-2026
yahoo.com
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
05-09-2026
yahoo.com
Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline
07-09-2026
yahoo.com
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
07-09-2026
yahoo.com
The Shingles Vaccine Is $0 at the Pharmacy. Get the Same Shot at Your Doctor’s Office and the Front Desk Asks for $200 Per Dose.
07-09-2026
247wallst.com
GHO Capital appoints Vivid Sehgal as Operating Partner
08-09-2026
yahoo.com
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff
10-09-2026
yahoo.com
GSK’s mRNA Flu Vaccine Shows Promise, But Can It Deliver Late-Stage?
11-09-2026
yahoo.com
What is the current price of GSK PLC (GLAXF:OTCMKTS)?
The current price of GSK PLC (GLAXF:OTCMKTS) is $24.
GSK PLC (GLAXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GSK PLC (GLAXF:OTCMKTS) since the previous trading day is $0.49.
GSK PLC (GLAXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GSK PLC (GLAXF:OTCMKTS) since the previous trading day is 2.0842%.
What is the most recent average sentiment score for GSK PLC (GLAXF:OTCMKTS)?
The most recent average sentiment score for GSK PLC (GLAXF:OTCMKTS) is 66 out of 100.
What is the most recent average sentiment for GSK PLC (GLAXF:OTCMKTS)?
The most recent sentiment for GSK PLC (GLAXF:OTCMKTS) is .
SEC-8K** Filing Available For GSK PLC (GLAXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.